<DOC>
	<DOCNO>NCT00489307</DOCNO>
	<brief_summary>The goal clinical research study learn dexamethasone help control symptoms fatigue , pain , nausea , weight loss , loss appetite , sleep problem , and/or depression patient advance cancer .</brief_summary>
	<brief_title>Dexamethasone Symptom Burden Advanced Cancer Patients</brief_title>
	<detailed_description>Dexamethasone decrease inflammation also suppress immune system . If find eligible study , randomly assign ( toss coin ) receive either dexamethasone placebo mouth morning night food every day 14 day . A placebo substance look like study drug active ingredient . You equal chance place either 2 group . You , medical staff , researcher know group assign . Beginning Day 15 [ ± 3 day ] , regardless assign dexamethasone placebo group first 14 day , begin receive dexamethasone . On Days 15-21 , receive dexamethasone 2 time day . On Days 22-28 continue take dexamethasone 2 time day , low dose level . If develop intolerable side effect study , medication stop remove study . You ask return outpatient clinic Days 8 [ ± 3 day ] , 15 [ ± 3 day ] , 22 [ ± 3 day ] , 29 [ ± 3 day ] answer questionnaire cancer diagnosis , medication taking , symptom ( example , pain , fatigue , nausea , appetite problem , sleep problem , depression , overall sense well-being ) . The questionnaire take approximately 30 minute complete . Blood ( 1 tablespoon ) drawn measure protein level check iron level blood . If unable return clinic day 8 , 15 , 22 , 29 ; assessment do research nurse phone ; blood work do . You consider off-study Day 29 [ ± 3 day ] . All study patient 2 week follow-up day 43 [ ± 3 day ] study drug discontinue , safety toxicity assessment . If unable return clinic day 43 , research nurse safety toxicity assessment phone . This investigational study . Dexamethasone approve FDA commercially available drug . It FDA approve dose level . Its use study , purpose , investigational . About 160 patient take part study . Up 110 enrol University Texas ( UT ) MD Anderson Cancer Center . The site participate study Lyndon Baines Johnson [ LBJ ] breast oncology clinic Houston Texas , Four Seasons Hospice Flat Rock , North Carolina .</detailed_description>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1 . Present 3 symptom last 24 hour ( Pain , fatigue , chronic nausea , anorexia/cachexia , sleep problem , depression poor appetite ) , average intensity &gt; /= 4 010 scale , 0= symptom , 10= bad possible symptom , 2 . No clinical evidence cognitive failure evidence Memorial Delirium Assessment Scale ( MDAS ) score 13 less baseline 3 . Must 18 year old 4 . No longer candidate aggressive anticancer therapysuch receptor blocker ( Iressa , etc . ) Patients oral palliative chemotherapy eligible study approve primary oncologist prior inclusion . Patients receive IV chemotherapy eligible study approve primary oncologist complete 1st line chemotherapy deem stable primary oncologist . The PI study obtain document approval primary oncologist patient 's study document . 5 . Life expectancy =/ &gt; 30 day 6 . Must understand sign write informed consent 7 . Patients topical , inhaled corticosteroid eligible study . If patient oral corticosteroid &lt; /= 7 day prior inclusion study eligible study . 1 . Allergy Dexamethasone 2 . Inability complete baseline assessment form 3 . Patients currently take Megestrol , drug &gt; 7 day 4 . Anemia define &lt; 9 hemoglobin 5 . Known history human immunodeficiency virus ( HIV ) 6 . Neutropenia define absolute neutrophil count ( ANC ) &lt; 1500 cells/mm 7 . Patients history diabetes exclude . 8 . All major surgery thoracotomy etc. , require wound heal within last 2 week 9 . Those currently receive oral corticosteroid therapy corticosteroid therapy &gt; /= 8 day prior study inclusion 10 . Sepsis and/or acute , chronic , ongoing infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Advanced Cancer</keyword>
	<keyword>Solid Tumors</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Pain</keyword>
	<keyword>Nausea</keyword>
	<keyword>Anorexia</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Decadron</keyword>
	<keyword>Placebo</keyword>
</DOC>